Abstract
Immunologically mediated anaphylactic-type events are not uncommon with PE. The pathogenesis of these reactions is not well understood and demands further investigation. If a technique or equipment-related phenomenon can be identified, it should be addressed (e.g., replace the membrane for a more biocompatible membrane and use better rinsing procedures to eliminate ethylene oxide). Testing for specific relevant immunogen, either by in vivo or in vitro methods, if these methods are available, should be considered. If infusion of essential blood products is the most likely cause, then a premedication regimen may be helpful in preventing such reactions. As the risks and benefits of treatment are weighed, it is important to remember that every hive need not be eliminated. Instead, the goal is to prevent compromise to oxygenation and perfusion in both mother and fetus while comfort is maintained and drug-induced adverse effects are avoided.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.